Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.Arthur A. Hurwitz, James P. Allison, Barbara A. Foster et al.|PubMed|2000Cited by 427
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancerEugene D. Kwon, James P. Allison, Barbara A. Foster et al.|Proceedings of the National Academy of Sciences|1997Cited by 393
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapyEugene D. Kwon, Maurice B. Burg, Barbara A. Foster et al.|Proceedings of the National Academy of Sciences|1999Cited by 223
Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone MarrowRosalba Salcedo, Jon M. Wigginton, Julie A. Hixon et al.|The Journal of Immunology|2009Cited by 99